Background and Study Aims: Variceal bleeding is a major cause of mortality in liver cirrhosis. Therapeutic options include medical (vasoconstrictive/vasoactive drugs) and endoscopic (sclerotherapy/ligation) treatments. Most studies evaluating acute esophageal bleeding have included patients with both ongoing and recent bleeding. Therefore therapeutic efficacy in ongoing bleeding may not have been adequately determined in these studies. A meta-analysis was performed for two reasons: first to compare directly the various treatments in the case of ongoing bleeding, as this would not be accomplished by a single trial, and secondly, to determine the success rates of each treatment option based on a larger number of patients.
Methods: An extensive Medline search identified 13 randomized controlled trials with precise statements of the number of patients with ongoing bleeding and their clinical outcomes. All studies followed a similar design and a Q test excluded heterogeneity of the studies. Data were pooled and cumulative success rates were calculated.
Results: Ligation appeared to be the most effective treatment (91.0 %, 95 % CI 82.4 - 96.3 %); it was significantly more successful than vasoconstrictive treatment (vasopressin/terlipressin 68.7 %, 61.7 - 75.2 %; P < 0.002, chi-squared-test) or vasoactive treatment (somatostatin/octreotide, 75.9 %, 68.1 - 82.6 %; P < 0.02) treatment, but was not statistically better than sclerotherapy (81.1 %, 71.7 - 88.4 %). The latter therapy was not statistically superior to medical treatment options. Calculations of estimated true effects, which take into account the weight of each study, rendered similar results.
Conclusion: Ligation is the most effective treatment option. No significant difference was found between the efficacy of sclerotherapy and treatment with somatostatin or octreotide.
References
1
Burroughs A K, D’Heygere F, McIntyre N.
Pitfalls in studies of prophylactic therapy for variceal bleeding in cirrhotics.
Hepatology.
1986;
6
1407-1413
3
Pascal J -P.
Non-surgical treatment of hemorrhage caused by portal hypertension in cirrhosis: hemostatic treatment, prevention of the first hemorrhage, prevention of recurrence.
Rev Prat.
1990;
40
1458-1461
4
Macdougall B R, Westaby D, Theodossi A, et al.
Increased long-term survival in variceal haemorrhage using injection sclerotherapy.
Lancet.
1982;
1
124-127
6
Imperiale T F, Teran J C, McCullough A J.
A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage.
Gastroenterology.
1995;
109
1289-1294
7
Stiegmann G V, Goff J S, Michaletz-Onody P A, et al.
Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices.
N Engl J Med.
1992;
326
1527-1532
8
Lo G H, Lai K H, Cheng J S, et al.
A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices.
Hepatology.
1995;
22
466-471
9
Nicolucci A, Grilli R, Alexanian A A, et al.
Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer.
JAMA.
1989;
262
2101-2107
10
Pagliaro L, D'Amico G, Sörensen T IA, et al.
Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment.
Ann Intern Med.
1992;
117
59-70
13
Freemann J G, Lishman A H, Cobden I, Record C O.
Controlled trial of terlipressin (‘glypressin’) versus vasopressin in the early treatment of oesophageal varices.
Lancet.
1982;
1
66-68
15
Jenkins S A, Baxter J N, Corbett W, et al.
A prospective randomized controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage.
BMJ.
1985;
290
275-278
16
Teres J, Planas R, Panes J, et al.
Vasopressin/nitroglycerin infusion vs. esophageal tamponade in the treatment of acute variceal bleeding: a randomized controlled trial.
Hepatology.
1990;
11
964-968
18
Saari A, Klvilaakso E, Inberg M, et al.
Comparison of somatostatin and vasopressin in bleeding esophageal varices.
Am J Gastroenterol.
1990;
85
804-807
19
Walker S, Kreichgauer H P, Bode C.
Terlipressin vs. somatostatin in bleeding esophageal varices: a controlled, double-blind study.
Hepatology.
1992;
15
1023-1030
20
Huang S J, Lin H C, Chang C F, et al.
A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding.
J Hepatol.
1992;
16
320-325
21
Shields R, Jenkins S A, Baxter J N, et al.
A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices.
J Hepatol.
1992;
16
128-137
22
Huang C C, Sheen I S, Chu C M, et al.
A prospective randomized controlled trial of sandostatin and vasopressin in the management of acute bleeding esophageal varices.
Chang Keng I Hsueh.
1992;
15 (2)
78-83
23
Silvain C, Carpentier S, Sautereau D, et al.
Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial.
Hepatology.
1993;
18
61-65
25
Gimson A ES, Ramage J K, Panos M Z, et al.
Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices.
Lancet.
1993;
342
391-394
26
de Franchis R, Arcidiacono P G, Carpinelli L, et al.
Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. New Italian Endoscopic Club.
Hepatology.
1993;
18
1102-1107
27
Laine L, el-Newihi H M, Migikovsky B, et al.
Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices.
Ann Intern Med.
1993;
119
1-7
28
Planas R, Quer J C, Boix J, et al.
A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding.
Hepatology.
1994;
20
370-375
29
D’Amico G, Traina M, Vizzini G, et al.
Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial. Liver Study group of V. Cervello Hospital.
J Hepatol.
1994;
20
206-212
31
Lo G H, Lai K H, Cheng J S, et al.
A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices.
Hepatology.
1995;
22
466-471
32
Hou M C, Lin H C, Kuo B I, et al.
Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial.
Hepatology.
1995;
21
1517-1522
34
Gotzsche P, Gjorup I, Bonnén H, et al.
Somatostatin vs. placebo in bleeding oesophageal varices: randomised trial and meta-analysis.
BMJ.
1995;
310
1495-1498
35
Walker S, Kreichgauer H P, Bode J C.
Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices - final report of a placebo-controlled, double-blind study.
Z Gastroenterol.
1996;
34
692-698
36
Feu F, Ruiz del Arbol L, et al.
Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group (see comments).
Gastroenterology.
1996;
111
1291-1299
37
Laine L, Stein C, Sharma V.
Randomized comparison of ligation versus ligation plus sclerotherapy in patients with bleeding esophageal varices.
Gastroenterology.
1996;
110
529-533
38
Jenkins S A, Shields R, Davies M, et al.
A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage.
Gut.
1997;
41
526-533
39
Lo G H, Lai K H, Cheng J S, et al.
Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices.
Hepatology.
1997;
25
1101-1104
40
Sarin S K, Govil A, Jain A K, et al.
Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence.
J Hepatol.
1997;
26 (4)
826-832
41
Avgerinos A, Nevens F, Raptis S, Fevery J.
Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial.
Lancet.
1997;
350
1495-1499
42
Villanueva C, Ortiz J, Sàbat M, et al.
Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial.
Hepatology.
1999;
30
384-389
43
Murata I, Yoshikawa I, Kume K, Otsuki M.
Short- and long-term results of endoscopic variceal ligation for esophageal varices compared with injection sclerotherapy.
J UOEH.
1999;
21
119-131
44
Djurdjevic D, Janosevic S, Dapcevic B, et al.
Combined ligation and sclerotherapy versus ligation alone for eradication of bleeding esophageal varices: a randomized and prospective trial.
Endoscopy.
1999;
31 (4)
286-290
46
Gross M, Zoller W G.
Medical prophylaxis of haemorrhage from oesophageal varices in patients with liver cirrhosis.
Eur J Gastroenterol Hepatol.
1997;
9
1-10
